DOJ announces settlement to allow CVS-Aetna merger
The Department of Justice’s Antitrust Division today announced a settlement that would allow CVS Health and Aetna to proceed with their proposed merger if Aetna divests its Medicare Part D prescription drug plans to WellCare. The settlement was filed in federal court as part of a civil antitrust lawsuit brought by the department and state attorneys general from California, Florida, Hawaii, Mississippi and Washington over competitive concerns with the merger. If approved by the court, the settlement would resolve those concerns, the agency said.
Related News Articles
Headline
The AHA expressed support Sept. 22 to House and Senate sponsors of the Medicare Advantage Prompt Pay Act (H.R. 5454/S. 2879), legislation that would apply a…
Headline
The Centers for Medicare & Medicaid Services Sept. 18 released a final rule on policy and technical changes to Medicare Advantage, the Medicare…
Headline
The AHA submitted a statement Sept. 17 for a House Ways and Means Committee markup session on a series of health care and other bills. Specifically, the AHA…
Headline
The AHA Sept. 15 expressed support for the Ensuring Access to Essential Providers Act, legislation that would require Medicare Advantage plans to cover…
Headline
The AHA Sept. 15 urged Aetna to rescind its recently announced “level of severity inpatient payment” policy, saying that it “could erode the transparency…
Perspective
Every health care provider strives to deliver their patients the best possible care, but not all providers offer the same level or complexity of care. Current…